Amgen disclosed that hackers stole company and patient information in a cloud data breach involving data hosted by third-party providers. Amgen said it detected unauthorized activity affecting data in July, stored on cloud platforms managed through external vendors. The company has not provided details on the scope or affected systems in the excerpted reporting. The incident reinforces heightened operational security scrutiny for large biopharma companies, particularly where sensitive patient information is involved and where third-party infrastructure expands the attack surface. For the industry, the breach may trigger additional compliance review, vendor security remediation, and potential downstream reporting obligations under applicable data protection rules.